Aliskiren and losartan trial in non-diabetic chronic kidney disease

Aliskiren and losartan trial in non-diabetic chronic kidney disease

Introduction: This is a report of a clinical trial on the therapeutic efficacy and safety of combined aliskiren and losartan (an angiotensin II receptor blocker (ARB)) versus aliskiren alone and ARB alone in non-diabetic chronic kidney disease (CKD) over a 3-year period. Materials and methods: This...

Full description

Bibliographic Details
Main Authors:	Keng-Thye Woo, Hui-Lin Choong, Kok-Seng Wong, Han-Kim Tan, Marjorie Foo, Stephanie Fook-Chong, Evan JC Lee, Vathsala Anantharaman, Grace SL Lee, Choong-Meng Chan
Format:	Article
Language:	English
Published:	Hindawi - SAGE Publishing 2014-12-01
Series:	Journal of the Renin-Angiotensin-Aldosterone System
Online Access:	https://doi.org/10.1177/1470320313510584

Similar Items

Influence of diabetes on efficacy of aliskiren, losartan or both on left ventricular mass regression
by: Orly Vardeny, et al.
Published: (2012-06-01)

Comparative evaluation of aliskiren, ramipril, and losartan on psychomotor performance in healthy volunteers: A preliminary report
by: Ekta Arora, et al.
Published: (2014-01-01)

Aliskiren accumulates in the kidney: does it matter?
by: David L Feldman, et al.
Published: (2008-03-01)

Combination therapy with aliskiren versus ramipril or losartan added to conventional therapy in patients with type 2 diabetes mellitus, uncontrolled hypertension and microalbuminuria
by: Egidio Imbalzano, et al.
Published: (2015-12-01)

Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
by: Kalathil K Sureshkumar
Published: (2008-12-01)

Aliskiren add-on therapy effectively reduces proteinuria in chronic kidney disease: An open-label prospective trial
by: Men-Tai Wu, et al.
Published: (2014-09-01)

Determining the Effects of Morphine, Heroin, and Losartan and the Interaction of each on Losartan in Water Homeostasis Mechanisms by the Kidney in Adult Male Rabbits
by: F Foroohi, et al.
Published: (2015-04-01)

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
by: Elizabeth Ripley, et al.
Published: (2010-06-01)

Aliskiren: A clinical profile
by: Roland E Schmieder
Published: (2006-06-01)

Aliskiren: a clinical profile
by: Roland E Schmieder
Published: (2006-06-01)

The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan
by: Ehécatl Miguel Ángel García Trejo, et al.
Published: (2017-09-01)

Combination of Chymostatin and Aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells
by: Miaojuan Qiu, et al.
Published: (2018-07-01)

Aliskiren: An orally active renin inhibitor
by: Pranay Wal, et al.
Published: (2011-01-01)

Review of direct renin inhibition by aliskiren
by: Stefanie Friedrich, et al.
Published: (2013-09-01)

The Value of Renal Biopsy in Non-Insulin-Dependent Diabetes Mellitus in Singapore over the Past Two Decades
by: Keng Thye Woo, et al.
Published: (2020-05-01)

Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease
by: Li Szu-yuan, et al.
Published: (2012-08-01)

Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria
by: Tsukasa Nakamura, et al.
Published: (2012-03-01)

Losartan improved antioxidant defense, renal function and structure of postischemic hypertensive kidney.
by: Milan Ivanov, et al.
Published: (2014-01-01)

ALISKIREN (RENIN INHIBITOR) AS THE RECENT ANTIHYPERTENSIVE MODALITY
by: Luh Gde Primahatini Suaka Putri
Published: (2013-12-01)

Aliskiren and valsartan combination therapy for the management of hypertension
by: Benjamin J Epstein
Published: (2010-08-01)

Role of aliskiren in blood pressure control and renoprotection
by: Hern&aacute;n Trimarchi
Published: (2011-03-01)

To study the protective effects of Aliskiren on myocardial infarction
by: Bo-Jhih Pan, et al.
Published: (2013)

Therapeutic Effects of Mouse Adipose-Derived Stem Cells and Losartan in the Skeletal Muscle of Injured Mdx Mice
by: Eun-Mi Lee, et al.
Published: (2015-05-01)

4.1 EFFECT OF ALISKIREN ON VASCULAR REMODELING IN SMALL RETINAL CIRCULATION
by: Christian Ott*, et al.
Published: (2015-11-01)

Bioprocess strategy for the production of Lactobacillus Rhamnosus NRRL B442 high cell-beta-glucosidase activity
by: Kok, Fook Seng
Published: (2014)

Pryamoy ingibitor renina aliskiren: novye gorizonty nefroprotektsii
by: S V Villeval'de, et al.
Published: (2010-06-01)

Clinical and economic impact of aliskiren in uncontrolled hypertensive patients
by: Ezio Degli Esposti, et al.
Published: (2012-03-01)

Aliskiren – pierwszy przedstawiciel nowej grupy leków hipotensyjnych
by: Katarzyna Job, et al.
Published: (2009-09-01)

Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
by: F. N. Ramalho, et al.
Published: (2017-10-01)

The effects and mechanisms of aliskiren on angiogenesis in experimental diabetes mellitus
by: Ting-Ting Chang, et al.
Published: (2015)

Protective effects of aliskiren and valsartan in mice with diabetic nephropathy
by: Weidong Wang, et al.
Published: (2014-12-01)

Haemodynamic effects of aliskiren in decompensated severe heart failure
by: Euler O Brancalhao, et al.
Published: (2012-03-01)

Direct renin inhibitor aliskiren in surgical treatment of nephrolithiasis
by: A.N., et al.
Published: (2013-03-01)

Treatment with aliskiren ameliorates tacrolimus-induced nephrotoxicity in rats
by: Naif O Al-Harbi, et al.
Published: (2015-12-01)

Can aliskiren reduce the incidence of cough caused by ramipril?
by: Outi Saijonmaa, et al.
Published: (2008-09-01)

Exploring the effects of losartan on cognition
by: Mechaeil, Rasha
Published: (2009)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

Influence of Lisinopril and Losartan on Parameters of Cardiac Hemodynamics and Kidney Function in Patients with Congestive Heart Failure
by: Zulfiya D. Rasulova, et al.
Published: (2014-12-01)

Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan
by: Antônio Carlos Avanza Jr, et al.
Published: (2000-02-01)

COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
by: Selçuk Şen, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_mmgatt9jgchlcssb0kgqad4gqe